Developer docs
API playgroundTry for free, no card

Search company profiles

RxAll

Full company profile

uuid0000szw

Namestring
RxAll
Legal namestring
RxAll
Websiteurl
rxall.net
Company typeenum
Private
Founded yearint
2019
Descriptiontext

RxAll is a Nigeria-headquartered healthtech company that operates a digital infrastructure platform for pharmaceutical supply chain integrity, primarily serving African and Southeast Asian markets. Its core product is the RxScanner, a handheld AI/ML-powered IoT device that uses spectral chemometric modeling and computer vision to authenticate drug quality through packaging in 20 seconds, achieving 99.9% accuracy across 400+ drugs in its spectral library. The technology originated from 8+ years of research at Yale University and holds ISO and CE certifications. All RxScanner-authenticated results are stored on blockchain for supply chain traceability.

Beyond the hardware device, RxAll operates an integrated platform including RxDelivered (a marketplace of 200+ licensed pharmacies selling verified authentic medicines), RxPay (B2B inventory financing for pharmacies and wholesalers), RxPOS (pharmacy management software), Rx-APIs (digitization APIs for inventory, insurance claims, and invoice financing), RxAcademy (pharmacist training with up to $10K in financing per person), RxHMO (insurance integration), and RxGO (curated pharmacy network). The company targets government regulators (notably NAFDAC in Nigeria, authenticating 100K+ drugs monthly), wholesalers, pharmacies, hospitals, and individual buyers. Revenue is generated through hardware unit sales, marketplace commissions, financing fees, software subscriptions, and API licensing. The company has raised approximately $6.78M across multiple rounds from investors including SOSV, Launch Africa Ventures, Loftyinc, Plug and Play, Katapult, and Savannah Fund, and operates with 11–50 employees.

Short descriptiontext

RxAll is a Nigeria-based healthtech company operating a digital pharmaceutical infrastructure platform centered on its AI-powered RxScanner device for drug authentication, serving regulators, wholesalers, pharmacies, and hospitals across Africa and Southeast Asia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew Haven, United States
HQ citystring
New Haven
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
drug authentication technology, pharmaceutical supply chain, pharmacy management software, counterfeit drug detection, healthcare financing platform
Industry3 codes
PRIMARYHLAGAJAK
Pharmacovigilance & Drug Safety Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
NAICS code3 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Custom Computer Programming Services541511
SIC code3 codes
  • Services-Prepackaged Software7372
  • Surgical & Medical Instruments & Apparatus3841
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Pharmaceutical Authentication Technology
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1RxScanner Device Sales
TypeHardware Sales
Description

Sale of the RxScanner handheld IoT device, which uses AI and machine learning to authenticate drug quality. The device is sold to FDAs, hospitals, pharmacies, wholesalers, and NGOs for on-site drug quality testing. Pricing is quoted per unit with bulk inquiries supported.

rxall.net
2RxDelivered Marketplace Commission
TypeMarketplace Commission
Description

RxDelivered connects buyers with verified sellers of authentic medicines. The platform likely earns commissions on transactions facilitated between buyers and sellers through the authenticated marketplace. 200+ licensed marketplaces are listed.

rxall.net
3RxPay Financing Services
TypeTransaction Fee
Description

RxPay enables pharmacies and wholesalers to get funding on soft terms for required purchases, preventing stock-outs. Revenue may come from financing fees charged on loans extended to pharmacies and wholesalers. RxAcademy also provides up to $10K inventory and asset financing per person.

rxall.net
4Rx-APIs Licensing
TypeLicensing Royalties
Description

RxAll offers inventory, insurance claims, and invoice financing APIs to third parties, generating licensing or usage-based revenue from pharmacies, HMOs, and healthcare systems that integrate RxAll's digital infrastructure.

rxall.net
5RxPOS Software
TypeSubscription Recurring
Description

Sales and purchases software for pharmacies providing automated inventory management, reordering, and transaction processing. Likely generates subscription or per-seat revenue from pharmacy customers.

rxall.net
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1RxScanner hardware units sold to regulators, pharma companies, hospitals, and NGOs
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Quote-based per-unit pricing with volume discounts available for large deployments. Target buyers include regulators/NGOs, pharma/hospital, and big pharma segments.

rxall.net
2RxAcademy training platform with up to $10K financing
ModelOtherBilling cadenceMulti-year contract
Notes

RxAcademy provides on-demand training for pharmacists to open and run pharmacy businesses with access to up to $10K in inventory and asset financing per person. Training is free; financing amount is up to $10K.

rxall.net
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 8 records shown
1RxScanner
Description

Award-winning healthcare IoT platform that uses AI and machine learning to check and confirm drug quality. Portable device that provides real-time results via iOS and Android app with 99% accuracy, ISO and CE certified.

rxall.net
+7 more records
Core offering1 text field

RxAll provides a digital infrastructure platform for healthcare centered on the RxScanner, a handheld AI-powered IoT device that authenticates drug quality in 20 seconds with 99.9% accuracy. Surrounding the device is an ecosystem comprising the RxDelivered marketplace for verified medicines, RxPay B2B financing, RxPOS pharmacy management software, and Rx-APIs for third-party integration. The platform is designed to combat counterfeit drugs and enable pharmacies, hospitals, wholesalers, and government regulators to verify, source, finance, and manage medicines.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 100K+ drugs authenticated monthly across Nigeria with NAFDAC
+6 more records
Product overview1 text field

RxAll is a digital infrastructure platform for healthcare that provides a comprehensive ecosystem of products and services. The platform centers on RxScanner, an AI-powered drug authentication device that identifies drug quality through packaging using computer vision. RxScanner-verified products are then made available through RxDelivered, a trusted marketplace connecting buyers and sellers. The ecosystem is augmented by financial services (RxPay for B2B funding), point-of-sale software (RxPOS), pharmacy training (RxAcademy with up to $10K financing), insurance integration (RxHMO), and a curated pharmacy network (RxGO). The company also offers Rx-APIs for pharmacy digitization. The platform targets pharmacies, hospitals, wholesalers, government regulators, insurance companies, and lenders across the drug supply chain.

Product and service8 records
1RxScanner
CategoryDrug Authentication Device
Description

Handheld AI and machine learning IoT device that identifies drug samples and quality levels through packaging in 20 seconds with 99.9% accuracy, returning results to a mobile app. Built on 8+ years of Yale University research, ISO and CE certified, and used by regulators, hospitals, pharmacies, wholesalers, and NGOs.

2RxDelivered
CategoryPharmaceutical Marketplace
Description

Trusted online marketplace connecting buyers with proven sellers of RxScanner-verified authentic medicines at affordable prices, serving pharmacies, hospitals, and individual buyers across 200+ licensed marketplaces.

3RxPay
CategoryHealthcare Financing
Description

B2B financing platform that provides funding on soft terms to pharmacies and wholesalers to prevent stock-outs and keep authentic drugs accessible without driving prices up. RxAcademy program offers up to $10K-$20K in inventory and asset financing per pharmacist.

4RxPOS
CategoryPharmacy Management Software
Description

Sales and purchases software for pharmacies that automates transactions, enables quick payments and invoicing, manages inventory and reordering, and sends notifications when medications run out of stock or expire.

5Rx-APIs
CategoryPharmacy APIs
Description

Developer APIs that digitize pharmacy operations through inventory management, insurance claims processing, and invoice financing, enabling third-party healthcare systems, pharmacies, HMOs, and hospitals to integrate with RxAll's digital infrastructure.

6RxAcademy
CategoryPharmacy Training and Incubation
Description

On-demand training platform that teaches pharmacists how to open and run a pharmacy business, with access to up to $10K-$20K in inventory and asset financing per person for graduates.

7RxHMO
CategoryHealth Insurance Integration
Description

Health Maintenance Organization service that provides insured customers with access to authentic drugs from accredited pharmacies on RxDelivered, credits HMOs, and enables customers to get prescriptions faster.

8RxGO
CategoryPharmacy Network
Description

Curated pharmacy network offering authenticated quality drugs and consumer products available for in-person and online ordering with delivery, accessible via the RxDelivered platform.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

NAFDAC, Nigeria's drug regulatory body, partnered with RxAll to deploy RxScanner across post-marketing surveillance inspectors nationwide. Results: 100K+ drugs authenticated monthly across Nigeria, 400+ drugs in spectral library. This is RxAll's flagship government partnership demonstrating large-scale deployment.

2Ibadan Drug Fulfillment Center (IDFC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

IDFC used RxScanner to authenticate drug quality before supplying to 4K+ customers across Nigeria. Results: 500K+ patients accessed safe drugs, 50% sales growth, 150K+ drugs tested. IDFC serves as a key case study demonstrating RxAll's impact on the distribution chain.

rxall.net
Strategic tierCoreTypeStrategic or Co-development Partner
Description

E-Health Africa Clinics deployed RxScanner to detect fake anti-malarial drugs in Northern Nigeria. The partnership demonstrates RxAll's application in clinical settings with results: 30K+ antimalarials tested in 1 year.

Strategic tierFlagshipTypeImplementation/ SI/ Consulting Partner
Description

NAFDAC uses RxScanner to screen the quality of imported drugs at ports and during post-marketing surveillance. This government partnership provides wide-scale deployment of RxAll's technology across Nigeria's drug quality monitoring infrastructure.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sproxil is a Nigeria-headquartered pharma anti-counterfeiting company using mobile verification (SMS/app-based codes) to authenticate drugs, directly competing with RxAll's RxScanner in the same African markets and customer base.

TypeDirect peer
Description

mPedigree is a Ghana-based drug authentication platform using mobile verification codes, serving the same pharmaceutical supply chain integrity use case as RxAll in West and East African markets.

TypeDirect peer
Description

PharmaSecure provides SMS-based authentication and serialization for pharmaceuticals in emerging markets (notably India and Africa), directly comparable to RxAll's anti-counterfeit drug authentication offering.

4Systech (Dover)
TypeBroad incumbent
Description

Systech provides pharmaceutical serialization, traceability, and authentication solutions as part of Dover's broader industrial portfolio, offering overlapping drug authentication capabilities to global pharma manufacturers.

TypeBroad incumbent
Description

Optel is a global pharma supply chain traceability and serialization company serving large pharma manufacturers with end-to-end track-and-trace platforms that compete with RxAll at the manufacturing/distribution tier.

TypeEmerging player
Description

TruTag develops ingestible spectral tag authentication for pharmaceuticals and other products, representing an alternative technology approach (tag-based vs RxScanner's hyperspectral scanning) to drug authentication.

TypeDirect peer
Description

RxERP provides pharmacy management and ERP software to African pharmacies, overlapping with RxAll's RxPOS offering for the same pharmacist customer base and pharmacy digitization use case.

TypeRegional player
Description

Tola Mobile provides fintech and inventory financing infrastructure for African SMEs including pharmacies, comparable to RxAll's RxPay B2B financing and Rx-APIs integration offerings across East Africa.

TypeBroad incumbent
Description

SAP's ATTP and pharmaceutical supply chain solutions serve large global pharma manufacturers with serialization and traceability, representing an enterprise incumbent whose adoption by multinational pharma could limit RxAll's addressable market.

TypeEmerging player
Description

Zipline is a drone-based medical supply delivery company serving African hospitals and pharmacies, with overlapping customer base (hospitals, regulators, pharmacies) and adjacent supply chain integrity mission to RxAll's drug authentication work.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors19 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RxAll

Pharmaceutical Authentication Technologyrxall.net

RxAll is a Nigeria-based healthtech company operating a digital pharmaceutical infrastructure platform centered on its AI-powered RxScanner device for drug authentication, serving regulators, wholesalers, pharmacies, and hospitals across Africa and Southeast Asia.

What RxAll does

RxAll is a Nigeria-headquartered healthtech company that operates a digital infrastructure platform for pharmaceutical supply chain integrity, primarily serving African and Southeast Asian markets. Its core product is the RxScanner, a handheld AI/ML-powered IoT device that uses spectral chemometric modeling and computer vision to authenticate drug quality through packaging in 20 seconds, achieving 99.9% accuracy across 400+ drugs in its spectral library. The technology originated from 8+ years of research at Yale University and holds ISO and CE certifications. All RxScanner-authenticated results are stored on blockchain for supply chain traceability.

Beyond the hardware device, RxAll operates an integrated platform including RxDelivered (a marketplace of 200+ licensed pharmacies selling verified authentic medicines), RxPay (B2B inventory financing for pharmacies and wholesalers), RxPOS (pharmacy management software), Rx-APIs (digitization APIs for inventory, insurance claims, and invoice financing), RxAcademy (pharmacist training with up to $10K in financing per person), RxHMO (insurance integration), and RxGO (curated pharmacy network). The company targets government regulators (notably NAFDAC in Nigeria, authenticating 100K+ drugs monthly), wholesalers, pharmacies, hospitals, and individual buyers. Revenue is generated through hardware unit sales, marketplace commissions, financing fees, software subscriptions, and API licensing. The company has raised approximately $6.78M across multiple rounds from investors including SOSV, Launch Africa Ventures, Loftyinc, Plug and Play, Katapult, and Savannah Fund, and operates with 11–50 employees.

RxAll firmographics

Firmographics
Name
RxAll
Legal name
RxAll
Website
https://rxall.net
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
RxAll is a Nigeria-based healthtech company operating a digital pharmaceutical infrastructure platform centered on its AI-powered RxScanner device for drug authentication, serving regulators, wholesalers, pharmacies, and hospitals across Africa and Southeast Asia.
Ownership category
akta.pro rank

RxAll industry classification

Industry
Product category
Pharmaceutical Authentication Technology
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), In-Vitro Diagnostic Substance Manufacturing (325413), Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAJAK
Pharmacovigilance & Drug Safety Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics

Keywords

  • Drug authentication technology
  • Pharmaceutical supply chain
  • Pharmacy management software
  • Counterfeit drug detection
  • Healthcare financing platform

Where RxAll is headquartered

Location

Headquarters

HQ city
New Haven
HQ country
United States
HQ region
North America

Offices1 record

Markets served

RxAll business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. RxScanner Device Sales: Sale of the RxScanner handheld IoT device, which uses AI and machine learning to authenticate drug quality. The device is sold to FDAs, hospitals, pharmacies, wholesalers, and NGOs for on-site drug quality testing. Pricing is quoted per unit with bulk inquiries supported.
  2. RxDelivered Marketplace Commission: RxDelivered connects buyers with verified sellers of authentic medicines. The platform likely earns commissions on transactions facilitated between buyers and sellers through the authenticated marketplace. 200+ licensed marketplaces are listed.
  3. RxPay Financing Services: RxPay enables pharmacies and wholesalers to get funding on soft terms for required purchases, preventing stock-outs. Revenue may come from financing fees charged on loans extended to pharmacies and wholesalers. RxAcademy also provides up to $10K inventory and asset financing per person.
  4. Rx-APIs Licensing: RxAll offers inventory, insurance claims, and invoice financing APIs to third parties, generating licensing or usage-based revenue from pharmacies, HMOs, and healthcare systems that integrate RxAll's digital infrastructure.
  5. RxPOS Software: Sales and purchases software for pharmacies providing automated inventory management, reordering, and transaction processing. Likely generates subscription or per-seat revenue from pharmacy customers.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goRxScanner hardware units sold to regulators, pharma companies, hospitals, and NGOs
OtherMulti-year contractRxAcademy training platform with up to $10K financing

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

RxAll product offering

Product offering

Core offering

RxAll provides a digital infrastructure platform for healthcare centered on the RxScanner, a handheld AI-powered IoT device that authenticates drug quality in 20 seconds with 99.9% accuracy. Surrounding the device is an ecosystem comprising the RxDelivered marketplace for verified medicines, RxPay B2B financing, RxPOS pharmacy management software, and Rx-APIs for third-party integration. The platform is designed to combat counterfeit drugs and enable pharmacies, hospitals, wholesalers, and government regulators to verify, source, finance, and manage medicines.

Product overview

RxAll is a digital infrastructure platform for healthcare that provides a comprehensive ecosystem of products and services. The platform centers on RxScanner, an AI-powered drug authentication device that identifies drug quality through packaging using computer vision. RxScanner-verified products are then made available through RxDelivered, a trusted marketplace connecting buyers and sellers. The ecosystem is augmented by financial services (RxPay for B2B funding), point-of-sale software (RxPOS), pharmacy training (RxAcademy with up to $10K financing), insurance integration (RxHMO), and a curated pharmacy network (RxGO). The company also offers Rx-APIs for pharmacy digitization. The platform targets pharmacies, hospitals, wholesalers, government regulators, insurance companies, and lenders across the drug supply chain.

Differentiator

Problem solved

Functional benefit

Brands

  • RxScanner: Award-winning healthcare IoT platform that uses AI and machine learning to check and confirm drug quality. Portable device that provides real-time results via iOS and Android app with 99% accuracy, ISO and CE certified.
  • RxDelivered
  • RxPay
  • Rx-APIs
  • RxPOS
  • RxAcademy
  • RxHMO
  • RxGO

Products and services

  • RxScanner Handheld AI and machine learning IoT device that identifies drug samples and quality levels through packaging in 20 seconds with 99.9% accuracy, returning results to a mobile app. Built on 8+ years of Yale University research, ISO and CE certified, and used by regulators, hospitals, pharmacies, wholesalers, and NGOs.
  • RxDelivered Trusted online marketplace connecting buyers with proven sellers of RxScanner-verified authentic medicines at affordable prices, serving pharmacies, hospitals, and individual buyers across 200+ licensed marketplaces.
  • RxPay B2B financing platform that provides funding on soft terms to pharmacies and wholesalers to prevent stock-outs and keep authentic drugs accessible without driving prices up. RxAcademy program offers up to $10K-$20K in inventory and asset financing per pharmacist.
  • RxPOS Sales and purchases software for pharmacies that automates transactions, enables quick payments and invoicing, manages inventory and reordering, and sends notifications when medications run out of stock or expire.
  • Rx-APIs Developer APIs that digitize pharmacy operations through inventory management, insurance claims processing, and invoice financing, enabling third-party healthcare systems, pharmacies, HMOs, and hospitals to integrate with RxAll's digital infrastructure.
  • RxAcademy On-demand training platform that teaches pharmacists how to open and run a pharmacy business, with access to up to $10K-$20K in inventory and asset financing per person for graduates.
  • RxHMO Health Maintenance Organization service that provides insured customers with access to authentic drugs from accredited pharmacies on RxDelivered, credits HMOs, and enables customers to get prescriptions faster.
  • RxGO Curated pharmacy network offering authenticated quality drugs and consumer products available for in-person and online ordering with delivery, accessible via the RxDelivered platform.

Quantifiable outcome

  • 100K+ drugs authenticated monthly across Nigeria with NAFDAC
  • +6 more outcomes

Companies that use RxAll

Customer profile

Named customers4 records

Segments7 records

Ideal customer profiles6 records

RxAll technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

RxAll partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered flagship and core.

  • NAFDAC (National Agency for Food and Drug Administration and Control)flagshipStrategic or Co-development PartnerNAFDAC, Nigeria's drug regulatory body, partnered with RxAll to deploy RxScanner across post-marketing surveillance inspectors nationwide. Results: 100K+ drugs authenticated monthly across Nigeria, 400+ drugs in spectral library. This is RxAll's flagship government partnership demonstrating large-scale deployment.
  • Ibadan Drug Fulfillment Center (IDFC)coreStrategic or Co-development PartnerIDFC used RxScanner to authenticate drug quality before supplying to 4K+ customers across Nigeria. Results: 500K+ patients accessed safe drugs, 50% sales growth, 150K+ drugs tested. IDFC serves as a key case study demonstrating RxAll's impact on the distribution chain.
  • E-Health Africa Clinics (EHA)coreStrategic or Co-development PartnerE-Health Africa Clinics deployed RxScanner to detect fake anti-malarial drugs in Northern Nigeria. The partnership demonstrates RxAll's application in clinical settings with results: 30K+ antimalarials tested in 1 year.
  • NAFDAC / Nigeria FDAflagshipImplementation/ SI/ Consulting PartnerNAFDAC uses RxScanner to screen the quality of imported drugs at ports and during post-marketing surveillance. This government partnership provides wide-scale deployment of RxAll's technology across Nigeria's drug quality monitoring infrastructure.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

RxAll competitors and assessment

Company assessment

Direct peers

  • Sproxil: Sproxil is a Nigeria-headquartered pharma anti-counterfeiting company using mobile verification (SMS/app-based codes) to authenticate drugs, directly competing with RxAll's RxScanner in the same African markets and customer base.
  • mPedigree (now RxAfrika): mPedigree is a Ghana-based drug authentication platform using mobile verification codes, serving the same pharmaceutical supply chain integrity use case as RxAll in West and East African markets.
  • PharmaSecure: PharmaSecure provides SMS-based authentication and serialization for pharmaceuticals in emerging markets (notably India and Africa), directly comparable to RxAll's anti-counterfeit drug authentication offering.
  • RxERP (mPedigree Group): RxERP provides pharmacy management and ERP software to African pharmacies, overlapping with RxAll's RxPOS offering for the same pharmacist customer base and pharmacy digitization use case.

Broad incumbents

  • Systech (Dover): Systech provides pharmaceutical serialization, traceability, and authentication solutions as part of Dover's broader industrial portfolio, offering overlapping drug authentication capabilities to global pharma manufacturers.
  • Optel Group: Optel is a global pharma supply chain traceability and serialization company serving large pharma manufacturers with end-to-end track-and-trace platforms that compete with RxAll at the manufacturing/distribution tier.
  • SAP (Advanced Track and Trace): SAP's ATTP and pharmaceutical supply chain solutions serve large global pharma manufacturers with serialization and traceability, representing an enterprise incumbent whose adoption by multinational pharma could limit RxAll's addressable market.

Emerging players

  • TruTag Technologies: TruTag develops ingestible spectral tag authentication for pharmaceuticals and other products, representing an alternative technology approach (tag-based vs RxScanner's hyperspectral scanning) to drug authentication.
  • Zipline: Zipline is a drone-based medical supply delivery company serving African hospitals and pharmacies, with overlapping customer base (hospitals, regulators, pharmacies) and adjacent supply chain integrity mission to RxAll's drug authentication work.

Regional players

  • Selcom / Tola Mobile: Tola Mobile provides fintech and inventory financing infrastructure for African SMEs including pharmacies, comparable to RxAll's RxPay B2B financing and Rx-APIs integration offerings across East Africa.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

RxAll social profiles

Digital presence

RxAll compliance and trust

Trust signal

Compliance2 records

RxAll financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RxAll leadership team

Management profile

Number of profiles

Profiles9 records

RxAll funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors19 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RxAll M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RxAll

What does RxAll do?

RxAll provides a digital infrastructure platform for healthcare centered on the RxScanner, a handheld AI-powered IoT device that authenticates drug quality in 20 seconds with 99.9% accuracy. Surrounding the device is an ecosystem comprising the RxDelivered marketplace for verified medicines, RxPay B2B financing, RxPOS pharmacy management software, and Rx-APIs for third-party integration. The platform is designed to combat counterfeit drugs and enable pharmacies, hospitals, wholesalers, and government regulators to verify, source, finance, and manage medicines.

Is RxAll a public or private company?

RxAll is a private company. It is classified as venture growth investor backed and is currently operating.

When was RxAll founded?

RxAll was founded in 2019. It employs 11 to 50 people.

Where is RxAll based?

RxAll is headquartered in New Haven, United States, in the North America region.

How does RxAll make money?

Five revenue lines are on record. RxScanner Device Sales are the primary driver. The others are rxDelivered Marketplace Commission, rxPay Financing Services, rx-APIs Licensing and rxPOS Software.

Who are RxAll's main competitors?

Direct peers on record are Sproxil, mPedigree (now RxAfrika), PharmaSecure and RxERP (mPedigree Group). Broad incumbents are Systech (Dover), Optel Group and SAP (Advanced Track and Trace). Emerging players are TruTag Technologies and Zipline. Selcom / Tola Mobile is listed as a regional player.

Does RxAll have an API?

Yes. Rx-APIs provide digitization capabilities for pharmacies through inventory, insurance claims, and invoice financing APIs. The APIs enable pharmacies to automate their operations, connect with financial services, and manage their supply chain digitally.

What industry is RxAll in?

RxAll's product category is Pharmaceutical Authentication Technology. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms. Its NAICS code is 3345 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WebProNewsSmaller AI Brains Take On Pharma’s Toughest ProblemsSmaller AI language models with tens to hundreds of millions of parameters are proving effective for specialized pharmaceutical tasks such as drug synergy prediction, counterfeit pill detection, and clinical documentation, challenging the assumption that only massive AI systems can deliver meaningful results. A December 2025 analysis in Pharmaceutical Technology and an April 2025 arXiv survey cite examples including RxAll's RxScanner for fake medicine detection and CancerGPT (124M parameters) delivering results competitive with larger systems at a fraction of the computational cost. Industry observers argue that before pharma companies can deploy autonomous AI agents, they must first train those agents on company-specific documentation to avoid hallucinated outputs and regulatory violations.IEEE SpectrumSmall Language Models Power Life-Saving Small AIRxAll founder Adebayo Alonge pivoted his counterfeit drug detection startup to develop a low-power, edge-based AI model capable of running on mobile devices without internet connectivity, following a failed demonstration in South Africa. The World Bank and various technology firms are increasingly promoting small AI as a sustainable solution for global health and agriculture in regions lacking robust infrastructure. This shift highlights a growing industry trend towards deploying specialized, low-resource models on edge hardware like smartphones and microcontrollers.Fast CompanyThis tech is using AI to eliminate counterfeit prescription drugsRxAll, launched in 2016, aims to combat counterfeit medications in Africa through its RXScanner, which employs AI and light spectroscopy. The company has seen significant growth, doubling its network to over 5,000 pharmacy locations and removing 1.3 million counterfeit drugs from the supply chain. RxAll is also collaborating with government agencies to enhance drug safety and public awareness about counterfeiting issues.YaleNewsInc. Magazine Names Amy Kao ’17, Co-founder of RxAll, to its 2025 Female Founders 500 ListInc. Magazine named Amy Kao, co-founder of RxAll, to its 2025 Female Founders 500 list, recognizing her leadership in expanding healthcare access in emerging markets. In 2024, RxAll supported 30 million patients and 5,000 pharmacies across Africa while establishing partnerships with major pharmaceutical companies including AstraZeneca, GSK, and Merck. The company continues to expand its impact through initiatives like AI-driven disease mapping and digital infrastructure for African pharmacies.YahooYale University Graduates Are Behind An AI-Powered Device That Can Detect Counterfeit DrugsYale graduates founded RxAll, an AI-powered device that authenticates medicines in 20 seconds with 99.9% accuracy. The company has raised $3.15 million and plans a Series A to expand into Asia.TechpointAfrican healthtech startups use blockchain, AI to combat counterfeit drugsAfrican healthtech startups use blockchain, AI, and mobile tech to combat counterfeit drugs, which the UNODC says cause about 500,000 deaths yearly in sub-Saharan Africa. Startups like mPedigree, Chekkit, and RxAll provide authentication tools, while blockchain platforms like Medsaf track supply chains.TechCrunchRxAll grabs $3.15M to scale its drug checking and counterfeiting tech across AfricaRxAll, a U.S.-Nigeria startup, raised $3.15 million to scale its drug authentication technology across Africa. The company's RxScanner handheld device verifies prescription drugs in 20 seconds, and it serves over 1 million patients in Nigeria. It plans to add 14 cities before year-end and expand pan-African operations next year.IFTTTFFA invests in Nigerian healthtech startup to reduce fake medicineFounders Factory Africa selected Nigerian healthtech startup RxAll for its six-month Venture Scale Programme, with Netcare and Standard Bank as investors. RxAll's RxScanner detects prescription drug quality in seconds, aiming to reduce fake medicine distribution. The programme provides $300,000 in support services and cash.Disrupt-africaNigerian e-health startup RxAll joins Founders Factory Africa’s Venture Scale programme, banks funding – Old Disrupt AfricaNigerian e-health startup RxAll has been selected to join Founders Factory Africa’s Venture Scale programme, receiving GBP80,000 in funding and strategic support services. This initiative is backed by partners including Standard Bank and Netcare, aiming to scale disruptive tech startups across the continent over the next five years. The partnership provides RxAll with resources to expand its platform for authenticating and delivering high-quality medicines.DevexTech solutions to fight fake medicinesRxAll and FarmaTrust are using AI and blockchain to detect and track fake medicines, with RxAll's nanoscanner and FarmaTrust's digital twin. WHO estimates one in 10 medical products in low- and middle-income countries is substandard or fake, and low- and middle-income countries spent about $30 billion on such drugs in 2017.